Toggle navigation
Home
Medical
IBD Risk 'Uncertain' in Biologic-Treated Patients With AxSpA
29-4-2022
Medical
https://www.medscape.com/cx/rssfeeds/2700.xml
96
'Enormous uncertainty' surrounds the risk of inflammatory bowel disease associated with biologic treatment in patients with axial spondyloarthritis. Medscape Medical News
Share
Tweet
+1
Read The Rest
at : https://www.medscape.com/cx/rssfeeds/2700.xml
Related News
Sugary Drinks May Up Risk Of Death From These Cancers
People With This Blood Type May Have Higher Risk Of Early...
3.85 Billion At Risk Of Infection Due To Healthcare...
Smart Socks Help Prevent Falls Among At-Risk Patients
Adderall Shortage Reported by Pharmacies, Patients
TAVR Now Used in Almost 50% of Younger Severe AS Patients
Abortion Laws Jeopardize Cancer Treatment for Pregnant...
Reduced Lactose Baby Formula May Raise Risk of Obesity Later
Excess weight, not high blood sugar, associated with...
Cancer patients facing housing instability show greater...